Cadonilimab plus chemotherapy as first-line treatment for persistent, recurrent, or metastatic cervical cancer: a cost-effectiveness analysis - Xiang, Zuojuan; Li, Zhengxiong; Chen, Xiaojuan; Fu, Yingzhou (Frontiers in Immunology, 2025)